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Introduction
When we talk about Autism Spectrum
Disorders (ASDs), we refer to a heterogeneous group
of neurodevelopmental disorders, that in the past
were just called “autism”. More than a single dis-
ease, today the term ASDs is referred to a group of
clinical conditions characterized by qualitative
impairment in social interaction and communication
and restricted, repetitive and stereotyped patterns of
behavior, interests and activities(1). These disorders
have a high prevalence in the population. Recent
data suggest a prevalence of 1:150 in the pediatric
population, with a M:F ratio of 4:1(2).
In the DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) Autism
Spectrum Disorders are included in the category of
Pervasive Developmental Disorders (PDD) and are
divided into five subtypes: autistic disorder, Rett syn-
drome, childhood disintegrative disorder (CDD),
Asperger syndrome, pervasive developmental disor-
der not otherwise specified (PDD-NOS)(3).
Moreover, we can distinguish two major cate-
gories of autism: “essential” autism and “complex”
or “syndromic” autism. Essential autism represents
about 75% of cases and is characterized by the
absence of dysmorphic features, M:F ratio of 6:1,
high risk of recurrence (up to 35%) and family histo-
ry (20% of cases). A complete and deep anamnestic
evaluation of patient history with special refer to
neonatal age when many risk factors (prematurity,
nosocomial infection, chemical media-
tors(4,5,6,7,8,9,10,11,12,13,14) is important for outcome.
Conversely, syndromic autism is generally
characterized by recognizable dysmorphic features.
It is important to distinguish these two categories,
because they have different prognosis and different
risk of recurrence for family members 15.
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ABSTRACT
Autism Spectrum Disorders (ASDs) are a heterogeneous group of neurodevelopmental disorders, characterized by qualitative
impairment in social interaction and communication and restricted, repetitive and stereotyped patterns of behavior, interests and
activities. They have a multifactorial etiology, but today different studies are showing the central role of genetics. Different genetic
alterations were detected: chromosomal abnormalities, mutations, trinucleotide repeats and copy number variations (CNVs).
Several studies identified many CNVs associated with ASDs and possible candidate genes, whose loss or gain could have a
key role in the etiopathogenesis of these disorders. In particular, they seem to be involved in neurogenesis, neuronal migration, dif-
ferentiation and degeneration.
We want emphasize that the final phenotype is variable, related not only to the genetic background but also to environmental
factors.
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As revealed by multiple independent studies
of families, the concordance rate between monozy-
gotic twins is 90%, compared to 10% among dizy-
gotic twins(16).
These studies also highlighted the existence of
significant genetic heterogeneity. Genetic alter-
ations can be inherited according to Mendelian
schemes with variable penetrance (autosomal or X-
linked) or can be de novo(17,18,19). Different genetic
alterations were detected: chromosomal abnormali-
ties, mutations, trinucleotide repeats and, as shown
by recent studies, copy number variations
(CNVs)(20,21,22,23,24,25).
Furthermore, a large number of genetic syn-
dromes(26,27,28,29,30) can occur with ASDs. Modern
research in genetics has focused attention on the
role in the etiology of ASDs of copy number varia-
tions, that are submicroscopic alterations of the
genome in excess or defect (microdeletions and
microduplications).
Discussion
Recent studies are revealing the possible
involvement of copy number variations as suscepti-
bility factors for complex diseases of unknown eti-
ology, such as schizophrenia or autism. Although
some CNVs were already known to cause global
development disorders, today array-CGH (compar-
ative genomic hybridization) allow the identifica-
tion of other CNVs associated with mental retarda-
tion, Autism Spectrum Disorders and schizophre-
nia. Array-CGH revealed that about 15% of patients
with “chromosomal” phenotype and normal kary-
otype are carriers of cryptic chromosomal imbal-
ance responsible for their condition(31).
These rearrangements are mediated by nonal-
lelic homologous recombination (NAHR), that
occurs during meiosis; it is usually flanked by
duplicons, or low copy repeats (LCRs). They are
blocks of a few repeated sequences, with very high
mutual homology (from 90% to 100%) and several
hundreds of kilobases (200-400 Kb). They are
throughout the genome, representing up to 5% of
the human genome, and are located in subtelomeric
and pericentromeric regions. Duplicons give the
DNA region high instability and susceptibility to
the onset of genomic rearrangements due to the cre-
ation of breaking points. So they can lead to errors
in recombination during meiotic crossing over
resulting in inversions, translocations, duplications
or deletions.
Generally microdeletions are more frequent
than microduplications. Microdeletions can be the
result of different recombination mechanisms
(intra-chromatid, inter-chromatid or intrachromoso-
mal), while microduplications are due to inter-chro-
matid or intrachromosomal recombination.
Microdeletions give specific and more severe signs
and symptoms, compared to the mild clinical fea-
tures due to microduplications. CNVs are character-
ized by complex inheritance, given by the interac-
tion with other alleles and with environmental fac-
tors. Several studies associate the same CNVs to
different phenotypes, including autism, atypical
autism, dyslexia, mental retardation and attention
deficit-hyperactivity disorder (ADHD).
These findings suggest that CNVs represent
predisposing genetic alterations leading to a vari-
able final phenotype, related with the genetic back-
ground and the environment(32). It is also important
to note that CNVs can be detected even in normal
population. Moreover, recent studies have identified
CNVs that contain genes whose products are
involved in cellular processes that begin in the early
stages of central nervous system development. In
particular, they seem to be involved in neurogene-
sis, neuronal migration, differentiation and degener-
ation(33). An interesting CNV has recently been iden-
tified in the 16p11.2 region and it seems to occur in
more than 1% of individuals with ASDs(34,35).
Further studies have associated 16p11.2 microdele-
tion syndrome with language delay and facial dis-
morphism, without necessarily presenting a diagno-
sis of autism spectrum disorder(36,37,38,39,40). This CNV
has recurrent breakpoints defined by low copy
repeats and includes 27 genes. Different studies
suggest a possible role of CNVs that contain genes
belonging to the family of ubiquitin genes (like
UBE3A), as susceptibility factors for Autism
Spectrum Disorders.
An analysis of 427 families with a diagnosis
of Autism Spectrum Disorders described other
CNVs containing genes, such as DPP6 (7q36.2),
DPP10 (2q14.1) and PCDH9 (13q21.32). DPP6 and
DPP10 seem important regulators of neuronal
excitability, integration of signals through the den-
drites and synaptic plasticity. Table 1 reports a sum-
mary of CNVs with the corresponding phenotypes.
Candidate genes in ASDs susceptibility
In addition to the identification of CNVs, in
the last few years several studies have been under-
taken in order to identify possible candidate genes
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CNVs ASDs Intellectual disability Seizures Psychiatric disorders Dysmorpich features Language delay
CNTNAP2 + - + - - -
SHANK3 + + ¬- + - -
UBE3A + - - - - -
PARK2 + - - - - -
del16p11.2 + + + +/- - + + +
dup16p11.2 + + +/- +/- + +
RFWD2 + - - - - -
FBXO40 + - - - - -
DPP6 + - - - - -
DPP10 + - - - - -
PCDH9 + - - - - -
PTCHD1 + + + - - - -
Table 1: CNVs associated with their phenotypic features.
Candidate genes in
ASDs susceptibility ASDs Intellectual disability Seizures Psychiatric disorders Dysmorpich features Language delay
NRNX1 + - - + - -
CNTN4 + - - - - -
NLGN3/4 + - - - - -
PCDH10 + + - - - -
DAI1 + + - - - -
NHE9 + + - - - -
PTEN + - - + - -
FOXP2 + - - - - +/-
RELN + - - - - -
LAMB1 + - - - - -
OXTR + - - - - -
AUTS2 + - - - - -
Table 1: Candidate genes in ASDs susceptibility.
with a key role in the etiopathogenesis of autistic
disorders. More genes are being identified, located
both on the autosomes and the sex chromosomes
(Table 2). CNTN4 is a gene located on chromo-
some 3 (3p26.3) encoding the CAM contactin 4, a
protein involved in the formation, maintenance and
plasticity of neuronal networks. Its break or its loss
cause cognitive delay, characteristic of 3p deletion
syndrome.
Even the long arm of chromosome 3 could be
involved in the etiology of ASDs; moreover recent
studies suggest an association between susceptibility
to ASDs and mutations of the gene NRXN1, located
in the 2p16.3 region, encoding for the neuroxine 1, a
protein with a role in the synaptogenesis.
4q28 deletions, involving the locus PCDH10,
have also been associated with ASDs. Proteins
essential for axonal growth appear to be encoded in
this region(41). PTEN is a tumor suppressor gene
located on chromosome 10 (10q23.3), that acts as a
negative regulator of the PI3 kinase pathway.
Heterozygous mutations in PTEN have been found
in a group of patients with autism, macrocephaly
and/or developmental delay(42). This gene is also
associated with Cowden syndrome, Zonana-
Ruvalcaba syndrome, Proteus syndrome and
Lhermitte-Duclos disease. Many candidate genes
for ASDs are located on chromosome 7.
On the long arm of this chromosome a suscep-
tibility locus for autism spectrum disorders, called
AUTS1, was found. Among these, candidate genes
the most studied are: FOXP2 (involved in a severe
monogenic form of language delay)(43), RELN and
LAMB1. On chromosome 7 were also identified
CNVs containing the gene for the contactin-associ-
ated protein-like 2, involved in neuronal migration
and cell adhesion.
In conclusion, even oxytocin plays an impor-
tant role in behavior and social interaction. OXTR
alleles with different single nucleotide polymor-
phisms (3p24-26) and haplotypes were associated
with ASDs.
Conclusions
The knowledge obtained so far emphasizes the
role of neurogenetics in the determining Autism
Spectrum Disorders. Further studies are required to
find and understand how these genetic abnormali-
ties contribute to the development of the disease.
One important finding is that both structural
and quantitative alterations can lead to different
effects in cellular processes. 
Genomic rearrangements could also be
responsible for alterations in transcription patterns.
Moreover, they could involve regulatory elements
and influence the expression of the closest genes.
Finally, we want to stress the importance of envi-
ronmental factors, which can act as triggers modi-
fying the phenotype.
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